Fragment-Based Drug Discovery
Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is hoped that this approval is just the beginning of the many drugs yet to be discovered using this fascinating technique. This book is written from a Chemist's perspective and comprehensively assesses the impact of fragment-based drug discovery on a wide variety of areas of medicinal chemistry. It will prove to be an invaluable resource for medicinal c…
Mehr
CHF 266.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
Weitere Autoren: Abell, Chris (Hrsg.)
- ISBN: 978-1-84973-908-5
- EAN: 9781849739085
- Produktnummer: 17522447
- Verlag: Royal Society Of Chemistry
- Sprache: Englisch
- Erscheinungsjahr: 2015
- Seitenangabe: 314 S.
- Masse: H23.9 cm x B16.3 cm x D2.3 cm 590 g
- Reihenbandnummer: 47
- Gewicht: 590
1 weiteres Werk von Steven (Hrsg.) Howard:
Bewertungen
Anmelden